Augmentin duo™ in the treatment of childhood blepharokeratoconjunctivitis.

  title={Augmentin duo™ in the treatment of childhood blepharokeratoconjunctivitis.},
  author={Jasmina Cehajic-Kapetanovic and Jeff Kwartz},
  journal={Journal of pediatric ophthalmology and strabismus},
  volume={47 6},
PURPOSE To report the use of Augmentin Duo 400/57 (GlaxoSmithKline, Middlesex, UK) in the treatment of childhood blepharokeratoconjunctivitis (BKC). METHODS This is a retrospective interventional case series. The case notes of 7 consecutive patients treated with Augmentin Duo 400/57 for BKC during 18 months were reviewed. Diagnostic criteria for BKC were blepharitis including recurrent chalazia and meibomian gland dysfunction, eyelid margin telangiectasia and facial rosacea, recurrent… CONTINUE READING


Publications citing this paper.

Similar Papers

Loading similar papers…